Avalo Therapeutics AVTX Remeasurement Of Lease
Remeasurement Of Lease at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept avtx:RemeasurementOfLease.
The official record: Avalo Therapeutics’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's remeasurement of lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's remeasurement of lease?
- Avalo Therapeutics (AVTX) reported remeasurement of lease of $0 in Q4 2025.
- How has Avalo Therapeutics's remeasurement of lease changed year-over-year?
- Avalo Therapeutics's remeasurement of lease decreased by 100.0% year-over-year, from $78K to $0.
- What does remeasurement of lease mean?
- Captures adjustments to the carrying value of lease liabilities resulting from changes in lease terms, modifications, or reassessments of lease duration. This non-cash or cash-neutral adjustment reflects the evolving nature of the company's real estate or equipment commitments. It is essential for understanding the accuracy of long-term liability reporting and operational footprint changes.